The pilot plant has achieved an average magnet rare earth recovery of 70% to MREC, consistent with continuous test work conducted by ANSTO, thereby validating the process flowsheet. Nameplate MREC ...

Feb 2026 - Investment portfolio outperforms market, declares higher fully franked interim dividend, and reports a substantial profit increase.

EBIT margin expanded by 30 basis points to 15.6%, with strong performances from Boral and WesTrac. NPAT saw a 2% increase to $518 million. The company’s revenue remained strong at $5.4 billion.

Feb 2026 - ASX-listed diversified operating company reports increased net profit and declares 32 cents per share dividend.

In light of the strong performance, CBA will distribute a fully franked interim dividend of $2.35 per share. This dividend represents a 4 per cent increase compared to the prior corresponding period ...

CSL has reported an underlying profit of $US1.9 billion ($2.68 billion) for the half-year ending December 31, a decrease of 7 per cent. Reported profit experienced a steeper decline, falling 81 per ...

Retail stocks came under pressure after December US retail sales were reported as flat, missing expectations for a modest monthly increase and slowing from November’s growth. Costco fell more than 2%, ...

Reflecting a strong balance sheet and cash flow, CSL has expanded its share buy-back program from US$500 million to US$750 million. The company has already achieved approximately 60% of its targeted ...

The sale is forecast to deliver a gain of approximately $NZ11 million for Fletcher Building. This gain will be recognised in the company’s FY26 EBIT (earnings before interest and taxes). The company ...

According to a statement released by the FCA on Tuesday, Dipesh Kerai and Bhavesh Hirani were found to have engaged in illegal insider trading activities involving Bidstack Group PLC shares. The FCA ...

Seven Group Holdings (SGH), the industrial conglomerate controlled by the Stokes family, has increased its interim dividend by 7 per cent to 32 cents per share. This decision follows the company’s ...

CSL is a global biotechnology leader that researches, develops, manufactures, and markets a range of plasma therapies, recombinant protein therapies, and influenza vaccines. This news prompted a 5 per ...